176 related articles for article (PubMed ID: 35562738)
1. 5-fluorouracil treatment of patient-derived scaffolds from colorectal cancer reveal clinically critical information.
Salerno S; Ståhlberg A; Holdfeldt A; Bexe Lindskog E; Landberg G
J Transl Med; 2022 May; 20(1):209. PubMed ID: 35562738
[TBL] [Abstract][Full Text] [Related]
2. Patient-derived scaffolds as a model of colorectal cancer.
Parkinson GT; Salerno S; Ranji P; Håkansson J; Bogestål Y; Wettergren Y; Ståhlberg A; Bexe Lindskog E; Landberg G
Cancer Med; 2021 Feb; 10(3):867-882. PubMed ID: 33356003
[TBL] [Abstract][Full Text] [Related]
3. Patient-derived scaffolds representing breast cancer microenvironments influence chemotherapy responses in adapted cancer cells consistent with clinical features.
Leiva MC; Gustafsson A; Garre E; Ståhlberg A; Kovács A; Helou K; Landberg G
J Transl Med; 2023 Dec; 21(1):924. PubMed ID: 38124067
[TBL] [Abstract][Full Text] [Related]
4. Decellularized matrices as in vitro models of extracellular matrix in tumor tissues at different malignant levels: Mechanism of 5-fluorouracil resistance in colorectal tumor cells.
Hoshiba T; Tanaka M
Biochim Biophys Acta; 2016 Nov; 1863(11):2749-2757. PubMed ID: 27558478
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer patient-derived scaffolds as a tool to monitor chemotherapy responses in human tumor microenvironments.
Leiva MC; Garre E; Gustafsson A; Svanström A; Bogestål Y; Håkansson J; Ståhlberg A; Landberg G
J Cell Physiol; 2021 Jun; 236(6):4709-4724. PubMed ID: 33368325
[TBL] [Abstract][Full Text] [Related]
6. Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer.
Huang X; Ke K; Jin W; Zhu Q; Zhu Q; Mei R; Zhang R; Yu S; Shou L; Sun X; Feng J; Duan T; Mou Y; Xie T; Wu Q; Sui X
Front Immunol; 2022; 13():887048. PubMed ID: 35784334
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs and drug resistance in colorectal cancer with special focus on 5-fluorouracil.
Pouya FD; Gazouli M; Rasmi Y; Lampropoulou DI; Nemati M
Mol Biol Rep; 2022 Jun; 49(6):5165-5178. PubMed ID: 35212928
[TBL] [Abstract][Full Text] [Related]
8. Esculetin enhances the inhibitory effect of 5-Fluorouracil on the proliferation, migration and epithelial-mesenchymal transition of colorectal cancer.
Yan L; Yu HH; Liu YS; Wang YS; Zhao WH
Cancer Biomark; 2019; 24(2):231-240. PubMed ID: 30689555
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer.
Nobili S; Napoli C; Landini I; Morganti M; Cianchi F; Valanzano R; Tonelli F; Cortesini C; Mazzei T; Mini E
Int J Cancer; 2011 Apr; 128(8):1935-45. PubMed ID: 20560137
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer: A Subgroup Analysis of the TOSCA Randomized Clinical Trial.
Petrelli F; Labianca R; Zaniboni A; Lonardi S; Galli F; Rulli E; Rosati G; Corallo S; Ronzoni M; Cardellino GG; Mattioli R; Mambrini A; Ciuffreda L; Banzi M; Pusceddu V; Maiello E; Zampino M; Zagonel V; Marchetti P; Corsi D; Rimassa L; Cinieri S; Sobrero A
JAMA Oncol; 2020 Apr; 6(4):547-551. PubMed ID: 32053133
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells.
Buhrmann C; Yazdi M; Popper B; Shayan P; Goel A; Aggarwal BB; Shakibaei M
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30002278
[No Abstract] [Full Text] [Related]
12. MicroRNA-23a antisense enhances 5-fluorouracil chemosensitivity through APAF-1/caspase-9 apoptotic pathway in colorectal cancer cells.
Shang J; Yang F; Wang Y; Wang Y; Xue G; Mei Q; Wang F; Sun S
J Cell Biochem; 2014 Apr; 115(4):772-84. PubMed ID: 24249161
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional signatures for coupled predictions of stage II and III colorectal cancer metastasis and fluorouracil-based adjuvant chemotherapy benefit.
Song K; Guo Y; Wang X; Cai H; Zheng W; Li N; Song X; Ao L; Guo Z; Zhao W
FASEB J; 2019 Jan; 33(1):151-162. PubMed ID: 29957060
[TBL] [Abstract][Full Text] [Related]
14. Dual drug loaded liposome bearing apigenin and 5-Fluorouracil for synergistic therapeutic efficacy in colorectal cancer.
Sen K; Banerjee S; Mandal M
Colloids Surf B Biointerfaces; 2019 Aug; 180():9-22. PubMed ID: 31015105
[TBL] [Abstract][Full Text] [Related]
15. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Adenosine Triphosphate-Based Chemotherapy Response Assay as a Predictor of Clinical Response to Fluorouracil-Based Adjuvant Chemotherapy in Stage II Colorectal Cancer.
Kwon HY; Kim IK; Kang J; Sohn SK; Lee KY
Cancer Res Treat; 2016 Jul; 48(3):970-7. PubMed ID: 26511802
[TBL] [Abstract][Full Text] [Related]
17. Identifying clinically relevant drug resistance genes in drug-induced resistant cancer cell lines and post-chemotherapy tissues.
Tong M; Zheng W; Lu X; Ao L; Li X; Guan Q; Cai H; Li M; Yan H; Guo Y; Chi P; Guo Z
Oncotarget; 2015 Dec; 6(38):41216-27. PubMed ID: 26515599
[TBL] [Abstract][Full Text] [Related]
18. Novel quinazolinone MJ‑33 induces AKT/mTOR‑mediated autophagy‑associated apoptosis in 5FU‑resistant colorectal cancer cells.
Ha HA; Chiang JH; Tsai FJ; Bau DT; Juan YN; Lo YH; Hour MJ; Yang JS
Oncol Rep; 2021 Feb; 45(2):680-692. PubMed ID: 33416156
[TBL] [Abstract][Full Text] [Related]
19. Association between poorly differentiated clusters and efficacy of 5-fluorouracil-based adjuvant chemotherapy in stage III colorectal cancer.
Tajima Y; Shimada Y; Kameyama H; Yagi R; Okamura T; Kobayashi T; Kosugi SI; Wakai T
Jpn J Clin Oncol; 2017 Apr; 47(4):313-320. PubMed ID: 28100684
[TBL] [Abstract][Full Text] [Related]
20. Predicting the effect of 5-fluorouracil-based adjuvant chemotherapy on colorectal cancer recurrence: A model using gene expression profiles.
Chen Q; Gao P; Song Y; Huang X; Xiao Q; Chen X; Lv X; Wang Z
Cancer Med; 2020 May; 9(9):3043-3056. PubMed ID: 32150672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]